Table 4.
Disease Progression Univariate and Multivariate Analysis.
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| HR (95% CI) | P Value | HR (95% CI) | P Value | |
| Age | .97 (.89–1.05) | .414 | — | |
| Sex | .792 | |||
| Male | Reference | — | ||
| Female | .91 (.45–1.83) | |||
| Performance status | .173 | — | ||
| <2 | Reference | — | ||
| ≥2 | 2.4 (.68–8.46) | |||
| T Stage | .185 | — | ||
| 1 and 2 | Reference | — | ||
| 3 and 4 | 1.63 (.79-3.38) | |||
| N stage | .109 | — | ||
| 0 | Reference | — | ||
| 1 and 2 | 2.09 (.85–5.13) | |||
| Tumor location | .430 | — | ||
| Body/tail | Reference | — | ||
| Head | 1.62 (.49–5.36) | |||
| Induction chemotherapy | .461 | — | ||
| No | Reference | — | ||
| Yes | 1.57 (.47–5.19) | |||
| Induction chemotherapy duration | .164 | — | ||
| <3 months | Reference | — | ||
| ≥3 months | .59 (.28-1.24) | |||
| Chemotherapy type | .862 | — | ||
| Other | Reference | — | ||
| FOLFIRINOX | .91 (.32–2.61) | |||
| Surgery | .025 | — | .045 | |
| No | Reference | — | Reference | — |
| Yes | .19 (.05–.82) | — | .22 (.05–.97) | — |
| Radiotherapy dose | .056 | — | .135 | |
| <50 Gy | Reference | — | Reference | — |
| 50 Gy | 3.30 (.97–11.23) | — | 2.54 (.74–8.64) | — |
| Elective coverage | .215 | — | ||
| No | Reference | — | ||
| Yes | .63 (.31–1.30) | |||
CI: confidence interval; HR: Hazard ratio.